Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients | ||||
Cardiovascular Research Prove Journal | ||||
Volume 7, Issue 2, December 2023 PDF (116.84 K) | ||||
Document Type: Abstracts | ||||
DOI: 10.21608/cvrepj.2023.351302 | ||||
![]() | ||||
Abstract | ||||
Transcatheter aortic valve implantation (TAVI) has become an established treatment option for the treatment of aortic stenosis throughout the spectrum of surgical risk. Cerebral embolic protection devices (CEPDs) were developed to protect against embolization from the valve or vasculature during or post- surgery. | ||||
Statistics Article View: 108 PDF Download: 43 |
||||